The majority of the market isn't seeing the bigger picture for these stocks and their underlying companies. Big mistake.

ASCO’s updated guidelines for advanced ovarian cancer emphasize health equity and provide new recommendations for HIPEC while ...

Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as ...

Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet, publishing phase 2 data that ...

Dogs of the Dow can be described as the 10 highest yielding stocks that are within the DJI. Read more to see the best Dog of ...

Glenmark Pharmaceuticals on Monday said it will pay USD 7 million to three entities to settle lawsuits in the US related to ...

Herbert Smith Freehills’ Priyanka Madan reports on a case involving a Merck SPC which was keenly anticipated by both ...

Shares of Viking Therapeutics VKTX rose nearly 8% on Friday after several third-party reports suggested that it was being ...

Glenmark Pharmaceuticals will pay USD 7 million to settle lawsuits in the US related to generic drugs, including Zetia and ...

Summit Therapeutics and Pfizer will work together to study Summit's promising cancer drug candidate ivonescimab and Pfizer's antibody drug conjugates, or ADCs, in solid tumors.

"The settlement makes clear that Glenmark denies each and every one of the allegations against it and the settlement is not ...